Get the Stockscreener App
33.75
0.90%
0.30
After Hours:
33.75
Sanara Medtech Inc stock is traded at $33.75, with a volume of 21,851.
It is up +0.90% in the last 24 hours and up +14.91% over the past month.
Sanara MedTech Inc is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the chronic and surgical wound and skincare markets. Its portfolio of products and services allows it to deliver comprehensive wound and skincare solutions for patients in all care settings, including acute and post-acute. Its surgical wound care products are CellerateRX Surgical Activated Collagen. Its chronic wound care products are HYCOL Hydrolyzed Collagen, BIAKOS Skin and Wound Cleanser, and BIAKOS Skin and Wound Gel.
See More
Previous Close:
$33.45
Open:
$33.5
24h Volume:
21,851
Relative Volume:
0.89
Market Cap:
$291.49M
Revenue:
$64.99M
Net Income/Loss:
$-4.30M
P/E Ratio:
-32.14
EPS:
-1.05
Net Cash Flow:
$-3.51M
1W Performance:
+4.17%
1M Performance:
+14.91%
6M Performance:
+4.04%
1Y Performance:
+25.05%
1-Day Range:
$32.91
$33.90
1-Week Range:
$31.50
$34.03
52-Week Range:
$26.00
$43.25
Sanara Medtech Inc Stock (SMTI) Company Profile
Name
Sanara Medtech Inc
Sector
Industry
Phone
817-529-2300
Address
1200 SUMMIT AVE, FORT WORTH
Sanara Medtech Inc Stock (SMTI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-20-22 | Resumed | Cantor Fitzgerald | Overweight |
| Jun-30-21 | Initiated | Cantor Fitzgerald | Overweight |
Sanara Medtech Inc Stock (SMTI) Latest News
Sanara MedTech (SMTI) to Release Quarterly Earnings on Tuesday - MarketBeat
(SMTI) Investment Analysis and Advice - Stock Traders Daily
Sanara MedTech Inc. (NASDAQ:SMTI) insiders have significant skin in the game with 30% ownership - Yahoo Finance
Sanara MedTech (NASDAQ:SMTI) Shares Up 1.5% – What’s Next? - Defense World
Sanara MedTech (NASDAQ:SMTI) Shares Up 1.5%Should You Buy? - MarketBeat
Sanara MedTech Inc. Announces Third Quarter Earnings Release and Conference Call Dates - GlobeNewswire
(SMTI) Investment Analysis - Stock Traders Daily
Retail investors who hold 32% of Sanara MedTech Inc. (NASDAQ:SMTI) gained 12%, insiders profited as well - Simply Wall St
Keith Myers named Sanara MedTech director - Medical Buyer
Sanara MedTech reshuffles board with new director - Investing.com
Sanara MedTech Board Evolution with Strategic New Appointment - TipRanks
Sanara MedTech Appoints Keith Myers to Board - citybiz
Sanara MedTech Inc. Announces Changes to Its Board of Directors - GlobeNewswire
InfuSystem, Sanara MedTech Partner For Distribution Deal - MPO-mag
InfuSystem, Sanara MedTech Partner for Distribution Deal - MPO-mag
(SMTI) On The My Stocks Page - Stock Traders Daily
Sanara MedTech (NASDAQ:SMTI) Trading Down 4.1% - Defense World
Analyzing Sanara MedTech (NASDAQ:SMTI) and Nutriband (NASDAQ:NTRB) - Defense World
Sanara MedTech Inc (SMTI) Shares Up 5.03% on Sep 27 - GuruFocus.com
Fort Worth health care company reaches compensation deal with new CEO - The Business Journals
Wound Cleanser Product Market to Surpass US$ 2.24 Billion, Expanding at a 1.4% CAGR by 2034: Fact.MR - GlobeNewswire Inc.
Sanara MedTech's (NASDAQ:SMTI) investors will be pleased with their solid 259% return over the last five years - Yahoo Finance
Sanara MedTech Inc. signs CEO Nixon to new employment terms - Investing.com India
Sanara MedTech Appoints Ronald T. Nixon as CEO with Incentive-Based Pay - TipRanks
(SMTI) Investment Report - Stock Traders Daily
Financial Analysis: Sanara MedTech (NASDAQ:SMTI) vs. Bone Biologics (NASDAQ:BBLG) - Defense World
Sanara MedTech Expands Portfolio with ChemoMouthpiece Investment - TipRanks
When (SMTI) Moves Investors should Listen - Stock Traders Daily
InfuSystem and Sanara MedTech Inc. Announce Exclusive United States Distribution Agreement with ChemoMouthpiece, LLC - BioSpace
Sanara MedTech and InfuSystem execute U.S. distribution agreement - TipRanks
Sanara MedTech Inc. and InfuSystem Holdings, Inc. Announce - GlobeNewswire
Sanara MedTech Inc. and InfuSystem Holdings, Inc. Announce Exclusive United States Distribution Agreement with, and Minority Investment in, ChemoMouthpiece, LLC - StockTitan
Sanara MedTech (NASDAQ:SMTI) Stock Price Up 4.8% - Defense World
Sanara MedTech (NASDAQ:SMTI) Shares Up 4.8% - MarketBeat
Sanara MedTech Inc. (NASDAQ:SMTI) Looks Just Right With A 28% Price Jump - Simply Wall St
Sanara MedTech Inc. (NASDAQ:SMTI) to Post FY2024 Earnings of ($2.03) Per Share, Cantor Fitzgerald Forecasts - MarketBeat
Cantor Fitzgerald Research Analysts Lower Earnings Estimates for Sanara MedTech Inc. (NASDAQ:SMTI) - Defense World
Price T Rowe Associates Inc. MD Has $215,000 Stake in Sanara MedTech Inc. (NASDAQ:SMTI) - Defense World
Vanguard Group Inc. Boosts Stake in Sanara MedTech Inc. (NASDAQ:SMTI) - Defense World
Sanara MedTech Inc. (NASDAQ:SMTI) Q2 2024 Earnings Call Transcript - Insider Monkey
Sanara MedTech Inc (SMTI) Q2 2024 Earnings Call Transcript Highl - GuruFocus.com
Sanara MedTech (NASDAQ:SMTI) Announces Quarterly Earnings Results - Defense World
Here's Why Sanara MedTech (NASDAQ:SMTI) Can Afford Some Debt - Simply Wall St
Sanara MedTech Second Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance
Sanara MedTech reports net loss of USD 3.5M for Q2 2024 - Medical Buyer
Sanara MedTech Inc (SMTI) Q2 2024 Earnings: Revenue Surpasses Es - GuruFocus.com
SMTI Stock Earnings: Sanara MedTech Misses EPS, Beats Revenue for Q2 2024 - InvestorPlace
Sanara MedTech Inc. Announces Second Quarter 2024 Results - GlobeNewswire
Sanara MedTech Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024 - Marketscreener.com
Sanara MedTech stock hits 52-week low at $26 - Investing.com
Sanara MedTech (SMTI) Set to Announce Quarterly Earnings on Monday - MarketBeat
Sanara Medtech Inc Stock (SMTI) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.98%
5.88%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):